Official UK procurement notice
Glatiramer Injection · UK public procurement notice
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)
What is being bought
Published requirement descriptionNo description was published on the notice. See the official documents.
CPV: Medicinal products for the nervous system · Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1This modification of contract term from 01/09/2022 to 28/02/2023 is to meet the…
This modification of contract term from 01/09/2022 to 28/02/2023 is to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015
Modification notice is advised at framework level and does not detail individual lots.
Procedure terms & legal framework
From the official record · publisher note attached- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 25 Jan 2022, 14:15 GMT
- Last source update
- 19 Aug 2022, 08:45 BST
- Authority reference
NP47818- FTS notice number
2022/S 000-023055- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-030f0bFind a Tender
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts: An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has be entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.
Publisher note: The estimated value of two (2) Lots referred to in Section V.2.4 covers the thirty-six (36) months of the framework length and fifteen (15) months extension period of the framework agreement. (SC Ref:702140)
How it was run
Official notice- Submission deadline
- —
Timeline
1 Jun 2018 → 19 Aug 2022 · 2 dates- Contract starts1 Jun 2018, 00:00 BST
- Notice published19 Aug 2022, 08:45 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Mylan, Teva UK Ltdjoint award | £11,005,352 †same award published again · counted once | — | Awarded |
| Mylan, Teva UK Ltdjoint award | £12,005,839 † | — | Awarded |
Contracts
Glatiramer Injection · Mylan, Teva UK Ltd
- Signed
- 20 Jul 2022
- Value
- £12,005,839
- Period
- … – 31 May 2021
- Status
- active
- Change This modification is to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015 Modification notice is advised at framework level and does not detail individual lots., Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: This modification is to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015 Modification notice is advised at framework level and does not detail individual lots.
Glatiramer Injection · Mylan, Teva UK Ltd
- Signed
- 1 May 2018
- Value
- £11,005,352
- Period
- 1 Mar 2022 – 31 Aug 2022
- Status
- active
- Change This modification of contract term from 01/03/2022 to 31/08/2022 is to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015 Modification notice is advised at framework level and does not detail individual lots., Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: This modification of contract term from 01/03/2022 to 31/08/2022 is to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015 Modification notice is advised at framework level and does not detail individual lots.
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Bidders & participating suppliers
3 commercial parties on the notice- MYLAN UK HEALTHCARE LIMITEDAwarded supplier
- MylanAwarded supplier
- Teva UK LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.